BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7608905)

  • 1. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.
    Arttamangkul S; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1995 Jun; 38(13):2410-7. PubMed ID: 7608905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.
    Meyer JP; Collins N; Lung FD; Davis P; Zalewska T; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1994 Nov; 37(23):3910-7. PubMed ID: 7966152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of highly potent and selective cyclic dynorphin A analogues.
    Kawasaki AM; Knapp RJ; Kramer TH; Wire WS; Vasquez OS; Yamamura HI; Burks TF; Hruby VJ
    J Med Chem; 1990 Jul; 33(7):1874-9. PubMed ID: 1972964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.
    Kawasaki AM; Knapp RJ; Kramer TH; Walton A; Wire WS; Hashimoto S; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    J Med Chem; 1993 Mar; 36(6):750-7. PubMed ID: 8096246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of highly potent and selective dynorphin A analogues as new medicines.
    Lung FD; Chen CH; Liu JH
    J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.
    Story SC; Murray TF; Delander GE; Aldrich JV
    Int J Pept Protein Res; 1992 Aug; 40(2):89-96. PubMed ID: 1359999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.
    Choi H; Murray TF; DeLander GE; Schmidt WK; Aldrich JV
    J Med Chem; 1997 Aug; 40(17):2733-9. PubMed ID: 9276018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
    Lu Y; Nguyen TM; Weltrowska G; Berezowska I; Lemieux C; Chung NN; Schiller PW
    J Med Chem; 2001 Sep; 44(19):3048-53. PubMed ID: 11543672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors.
    Aldrich JV; Zheng QI; Murray TF
    Chirality; 2001; 13(3):125-9. PubMed ID: 11270320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the conformational requirements for binding to the kappa-opioid receptor and its subtypes. I. Novel alpha-helical cyclic peptides and their role in receptor selectivity.
    Collins N; Hruby VJ
    Biopolymers; 1994 Sep; 34(9):1231-41. PubMed ID: 7948735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid.
    Snyder KR; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1993 Apr; 36(8):1100-3. PubMed ID: 8097539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1.
    Meyer JP; Davis P; Lee KB; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1995 Sep; 38(18):3462-8. PubMed ID: 7658433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10.
    Lemaire S; Lafrance L; Dumont M
    Int J Pept Protein Res; 1986 Mar; 27(3):300-5. PubMed ID: 2872177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10.
    Kawasaki AM; Knapp RJ; Walton A; Wire WS; Zalewska T; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    Int J Pept Protein Res; 1993 Nov; 42(5):411-9. PubMed ID: 7906258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.